Previous Close | 28.81 |
Open | 28.77 |
Bid | 27.65 x 100 |
Ask | 28.03 x 100 |
Day's Range | 27.22 - 28.77 |
52 Week Range | 20.88 - 53.38 |
Volume | |
Avg. Volume | 377,239 |
Market Cap | 194.805M |
Beta (5Y Monthly) | 1.01 |
PE Ratio (TTM) | 13.72 |
EPS (TTM) | 2.03 |
Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 40.00 |
Semler Scientific ( NASDAQ:SMLR ) Second Quarter 2024 Results Key Financial Results Revenue: US$14.5m (down 22% from 2Q...
Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the second quarter ended June 30, 2024. In addition, the Company announced the purchase of an additional 101 bitcoins for an aggregate amount of $6.0 million. Since announcing the adoption of a bitcoin treasury strategy on May 28, 2024, the Company has purchased 929 bitcoins for a total of $63.0 mil
Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the second quarter and six months ended June 30, 2024, after the close of U.S. financial markets on Monday, August 5, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Eric Semler, chairman, R